Yujie Zhao
Internist · Mayo Clinic College of Medicine and Science
Credentials: · · · · · · · ·
History
- 2010–2013
- 2007–2010
- 2003–2007
Doctor of Medicine
Research
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
Review · The Oncologist · 2015 · First of 2 authors · 438 citations
The clinical development of MEK inhibitors
Review · Nature Reviews Clinical Oncology · 2014 · First of 2 authors · 337 citations
Emerging therapeutic agents for advanced non-small cell lung cancer
Review · Journal of Hematology & Oncology · 2020 · 267 citations
28 papers
28 papers
15 papers
8 papers
7 papers · 2 as a fellow
- KS
6 papers · 6 as a fellow
6 papers
4 papers
Clinical trials
- 2024–2028
Site PI · Recruiting
Tempus AI
- 2024–2027
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
Site PI · Recruiting · Phase 1
SparX Biotech(Jiangsu) Co., Ltd.